EDWARDS JAMES MICHAEL (Chief Financial Officer) received a stock award from BIOAFFINITY TECHNOLOGIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/5/2024ACC: 0001493152-24-043707
Officer· Chief Financial Officer
Since Aug 2022
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
716.5%
11/5/2024
13.96K→113.96K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2024 | A · Award | +100K | — | — | 716.5% | 13.96K | 113.96K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported